✦ LIBER ✦

Pericarditis as a complication of infliximab therapy in Crohn's disease

✍ Scribed by J.P. Burke; B. Kelleher; S. Ramadan; M. Quinlan; D. Sugrue; M.A. O'Donovan

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 85 KB
Volume: 14
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.20270

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endoscopic monitoring of infliximab ther

Endoscopic monitoring of infliximab therapy in Crohn's disease

✍ Clas-Göran af Björkesten; Urpo Nieminen; Ulla Turunen; Perttu E. Arkkila; Taina 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 2 views

Endoscopic monitoring of infliximab ther

Endoscopic monitoring of infliximab therapy in Crohn's disease

✍ Clas-Göran af Björkesten; Urpo Nieminen; Ulla Turunen; Perttu E. Arkkila; Taina 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 1 views

## Background: So far, infliximab (ifx) therapy for the treatment of crohn's disease (cd) has generally been guided by clinical symptoms. data on treatment response as ascertained by endoscopy in ifx therapy are scarce. the aims of this study were to measure the endoscopic response rate during ifx

Combination therapy of infliximab and az

Combination therapy of infliximab and azathioprine reduces disease progression in Crohn's disease

✍ S. Din; C.J. Cochrane; C.L. Noble; J. Satsangi; I.D.R. Arnott 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

FIGURE 1. Disease progression. Kaplan-Meier analysis demonstrating disease progression over the follow-up period between the groups.

Psoas abscess: A complication of Crohn's

Psoas abscess: A complication of Crohn's disease

✍ C. J. Burul; Jean K. Ritchie; P. R. Hawley; Ian P. Todd 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

## Abstract Between 1971 and 1978 at St Mark's Hospital and St Bartholomew's Hospital, 8 patients were seen with a psoas abscess complicating Crohn's disease. All patients had a long history of disease and the diagnosis was usually obvious on clinical grounds. The abscess was drained in all patient

Changes of OPG and RANKL concentrations

Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy

✍ Pál Miheller; Györgyi Műzes; Károly Rácz; Anna Blázovits; Péter Lakatos; László 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

## Background: Osteoporosis is a well-known complication of crohn's disease (cd). osteoprotegerin (opg) concentration is elevated in patients with cd compared to healthy controls. long-term infliximab (ifx) maintenance therapy improves the patients' bone mineral density. the effect of ifx on bone m

Long-term outcome of maintenance inflixi

Long-term outcome of maintenance infliximab therapy in children with Crohn's disease

✍ Jeffrey S. Hyams; Trudy Lerer; Anne Griffiths; Marian Pfefferkorn; Subra Kugatha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i